Endocytic recycling compartments altered in cisplatin-resistant cancer cells

Cancer Research

Volumn 66, Issue 4, 2006, Pages 2346-2353

  Liang, Xing Jie ^a,c   Mukherjee, Sushmita ^b   Shen, Ding Wu ^a   Maxfield, Frederick R ^b   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CISPLATIN; SPHINGOMYELIN;

ADENOCARCINOMA; ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CARCINOMA CELL; CELL; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL STRAIN B104 5; CELL STRAIN KB 3 1; CELL STRAIN KB CP.5; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG UPTAKE; ENDOCYTIC RECYCLING COMPARTMENT; ENDOCYTOSIS; HUMAN; HUMAN CELL; LIPID METABOLISM; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

ANIMALS; CHO CELLS; CISPLATIN; CRICETINAE; DRUG RESISTANCE, NEOPLASM; ENDOCYTOSIS; ENDOSOMES; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; KB CELLS; LIPIDS; LYSOSOMES; SPHINGOMYELINS; TRANSFERRIN; TRANSPORT VESICLES; TUBULIN;

EID: 33644548947     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3436     Document Type: Article

References (44)

1. Wang G, Reed E, Li QQ. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer. Oncol Rep 2004;12:955-65.
2. Safaei R, Howell SB. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 2005;53:13-23.
3. Shen DW, Su A, Liang XJ, Pai-Panandiker A, Gottesman MM. Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells. Br J Cancer 2004;91:270-6.
4. Pinto AL, Lippard SJ. Binding of the antitumor drug cis- diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta 1985;780:167-80.
5. Chu G. Cellular response to cisplatin: The roles of DNA binding proteins and DNA repair. J Biol Chem 1994;269:787-90.
6. Siddik ZH. Biochemical and molecular mechanisms of cisplatin resistance. Cancer Treat Res 2002;112:263-84.
7. Speelmans G, Sips WH, Grisel RJ, et al. The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration. Biochim Biophys Acta 1996;1283:60-6.
8. Speelmans G, Staffhorst RW, Versluis K, Reedijk J, de Kruijff B. Cisplatin complexes with phosphatidylserine in membranes. Biochemistry 1997;36:10545-50.
9. Burger KN, Staffhorst RW, De Kruijff B. Interaction of the anti-cancer drug cisplatin with phosphatidylserine in intact and semi-intact cells. Biochim Biophys Acta 1999;1419:43-54.
10. Liang XJ, Yin JJ, Zhou JW, et al. Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells. Exp Cell Res 2004;293:283-91.
11. Maheswari KU, Ramachandran T, Rajaji D. Interaction of cisplatin with planar model membranes does dependent change in electrical characteristics. Biochim Biophys Acta 2000;1463:230-40.
12. Liang XJ, Shen DW, Garfield S, Gottesman MM. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Cancer Res 2003;63:5909-16.
13. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev 1997;77:759-803.
14. Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol 2004;5:121-32.
15. Nichols BJ, Kenworthy AK, Polishchuk RS, et al. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J Cell Biol 2001;153:529-41.
16. Hopkins CR, Trowbridge IS. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J Cell Biol 1983;97:508-21.
17. Akiyama S, Fojo A, Hanover JA, Pastan I, Gottesman MM. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 1985;11:117-26.
18. McGraw TE, Dunn KW, Maxfield FR. Isolation of a temperature-sensitive variant Chinese hamster ovary cell line with a morphologically altered endocytic recycling compartment. J Cell Physiol 1993;155:579-94.
19. Mukherjee S, Soe TT, Maxfield FR. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J Cell Biol 1999;144:71-1284.
20. Koval M, Pagano RE. Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts. J Cell Biol 1989;108:2169-81.
21. Mayor S, Presley JF, Maxfield FR. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J Cell Biol 1993;12:1257-69.
22. Pagano RE, Watanabe R, Wheatley C, Dominguez M. Applications of BODIPY-sphingolipid analogs to study lipid traffic and metabolism in cells. Methods Enzymol 2000;312:523-34.
23. Chauhan SS, Liang XJ, Su AW, et al. Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines. Br J Cancer 2003;88:1327-34.
24. Liang XJ, Shen DW, Chen KG, Wincovitch SM, Garfield SH, Gottesman MM. Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum. J Cell Physiol 2005;202:635-41.
25. Lipsky NG, Pagano RE. Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue. Proc Natl Acad Sci U S A 1983;80:2608-12.
26. Lipsky NG, Pagano RE. Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane. J Cell Biol 1985;100:27-34.
27. Lin SX Gundersen GG, Maxfield FR. Export from pericentriolar endocytic recycling compartment to cell surface depends on stable, detyrosinated (glu) microtubules and kinesin. Mol Biol Cell 2002;13:96-109.
28. Andrews PA, Howell SB. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cell 1990;2:35-43.
29. Stein WD, Litman T, Fojo T, Bates SE. Differential expression of cell adhesion genes: Implications for drug resistance. Int J Cancer 2005;113:861-5.
30. Brabec V, Kasparkova J. Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Updat 2002;5:147-61.
31. Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003;3:502-16.
32. 14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J Cell Physiol 2000;183:108-16.
33. Gruenberg J. Lipids in endocytic membrane transport and sorting. Curr Opin Cell Biol 2003;15:382-8.
34. Liang XJ, Shen DW, Gottesman MM. A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. J Inorg Biochem 2004;98:1599-606.
35. Gruenberg J, Stenmark H. The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004;5:317-23.
36. Coumailleau F, Das V, Alcover A, et al. Overexpression of Rififylin, a new RING finger and FYVE-like domain-containing protein, inhibits recycling from the endocytic recycling compartment. Mol Biol Cell 2004;15:4444-56.
37. 14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. Mol Pharmacol 2004;66:789-93.
38. Tulub AA, Stefanov VE. Cisplatin stops tubulin assembly into microtubules. A new insight into the mechanism of antitumor activity of platinum complexes. Int J Biol Macromol 2001;28:191-8.
39. Palazzo A, Ackerman B, Gundersen GG. Cell biology: Tubulin acetylation and cell motility, Nature 2003;421:230.
40. Webster DR, Wehland J, Weber K, Borisy GG. Detyrosination of α-tubulin does not stabilize microtubules in vivo. J Cell Biol 1990;111:113-22.
41. Wehland J, Weber K. Turnover of the carboxy-terminal tyrosine of α-tubulin and means of reaching elevated levels of detyrosination in living cells. J Cell Sci 1987;88:185-203.
42. Gundersen GG, Kalnoski MH, Bulinski JC. Distinct populations of microtubules: tyrosinated and nontyrosinated α-tubulin are distributed differently in vivo. Cell 1984;38:779-89.
43. Aggarwal SK, Whitehouse MW, Ramachandran C. Ultrastructural effects of cisplatin. In: Prestayko AW, Crooke ST, Carter SK, editors. Cisplatin: Current Status and New Development. New York: Academic Press; 1980.
44. Kopf-maier P, Huhlhausen SK. Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro. Chem Biol Interact 1992;82:295-316.